170 related articles for article (PubMed ID: 1260685)
1. A correlation of DNCB-induced delayed cutaneous hypersensitivity reactions and the course of disease in patients with recurrent breast cancer.
Cunningham TJ; Daut D; Wolfgang PE; Mellyn M; Maciolek S; Sponzo RW; Horton J
Cancer; 1976 Apr; 37(4):1696-1700. PubMed ID: 1260685
[TBL] [Abstract][Full Text] [Related]
2. Delayed cutaneous hypersensitivity reactions and prognosis in patients with cancer.
Pinsky CM; Wanebo H; Mike V; Oettgen H
Ann N Y Acad Sci; 1976; 276():407-10. PubMed ID: 1071969
[No Abstract] [Full Text] [Related]
3. Dinitrochlorobenzene skin sensitization and peripheral lymphocyte count: predictors of survival in head and neck cancer.
Maisel RH; Ogura JH
Ann Otol Rhinol Laryngol; 1976; 85(4 Pt 1):517-22. PubMed ID: 949158
[TBL] [Abstract][Full Text] [Related]
4. DNCB reactivity and prognosis in 419 patients with malignant melanoma.
Camacho ES; Pinsky CM; Braun DW; Golbey RB; Fortner JG; Wanebo HJ; Oettgen HF
Cancer; 1981 May; 47(10):2446-50. PubMed ID: 7272900
[TBL] [Abstract][Full Text] [Related]
5. Effect of levamisole on skin reactions to DNCB in chronically dialyzed patients.
Modai D; Sagi DB; Maor J
Nephron; 1980; 25(6):280-2. PubMed ID: 7393370
[TBL] [Abstract][Full Text] [Related]
6. Local delayed cutaneous hypersensitivity reactions in breast cancer patients with and without removal of axillary lymph nodes.
Schick PM; Shabot MM; Block JB; Rosenbloom BE; Burleigh J; Pilch YH
Am J Surg; 1976 Jul; 132(1):40-5. PubMed ID: 782264
[TBL] [Abstract][Full Text] [Related]
7. Sequential evaluation of DNCB reactivity in patients with primary lung cancer. Correlation with prognosis.
Inoue H; Ishihara T; Kobayashi K; Fukai S
J Thorac Cardiovasc Surg; 1978 Oct; 76(4):479-82. PubMed ID: 703354
[TBL] [Abstract][Full Text] [Related]
8. Immunological studies in psoriasis. The quantitative evaluation of cell-mediated immunity in patients with psoriasis by experimental sensitization to 2,4-dinitrochlorobenzene.
Obalek S; Haftek M; Sliński W
Dermatologica; 1977; 155(1):13-25. PubMed ID: 303184
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of skin testing with dinitrochlorobenzene in patients with head and neck cancer.
Osoba D; Kersey PA; Clark RM; Rosen IB
Can J Surg; 1980 Jan; 23(1):43-4. PubMed ID: 7363157
[TBL] [Abstract][Full Text] [Related]
10. Skin sensitization to 2, 4 dinitrochlorobenzene (DNCB) in the first months of life.
Cassimos C; Kanakoudi-Tsakalidis F; Spyroglou K; Ladianos M; Tzaphi R
J Clin Lab Immunol; 1980 Mar; 3(2):111-3. PubMed ID: 7205930
[TBL] [Abstract][Full Text] [Related]
11. [DNCB-skin specimens for immunodiagnosis].
Sinn W
Z Gesamte Inn Med; 1981 Sep; 36(17):602-7. PubMed ID: 7345806
[TBL] [Abstract][Full Text] [Related]
12. Delayed hypersensitivity to DNCB and survival following radiation therapy in patients with solid malignant tumors.
Hazra TA; Parks LC; Inalsingh A; Peeples W
Radiology; 1975 May; 115(2):429-30. PubMed ID: 1144761
[TBL] [Abstract][Full Text] [Related]
13. [Cross allergies following sensitization with dinitrochlorbenzol (DNCB)].
Djawari D; Körner E; Haneke E
Hautarzt; 1980 Apr; 31(4):198-202. PubMed ID: 7399912
[TBL] [Abstract][Full Text] [Related]
14. Studies on the dinitrochlorobenzene (DNCB) sensitization test.
Niwa Y; Niwa H; Kohmura J; Ou DW; Yokoyama MM
Ann Allergy; 1982 Feb; 48(2):108-12. PubMed ID: 7199878
[TBL] [Abstract][Full Text] [Related]
15. Studies on the retest reaction in contact sensitivity to DNCB.
Nakagawa S; Fukushiro S; Gotoh M; Kohda M; Namba M; Tanioku K
Dermatologica; 1978; 157(1):13-20. PubMed ID: 566682
[TBL] [Abstract][Full Text] [Related]
16. [A correlation between the histological parameters such as stromal reaction and cell-mediated immune-structure of the regional lymph nodes, and the delayed cutaneous hypersensitive reaction toward DNCB in cervical cancer (author's transl)].
Obata N; Kodama S; Hando T; Hirogami T; Takeuchi S
Nihon Sanka Fujinka Gakkai Zasshi; 1980 May; 32(5):550-8. PubMed ID: 7240843
[TBL] [Abstract][Full Text] [Related]
17. DNCB and PPD skin tests and prognosis in 152 patients with breast cancer. A prospective 2-year follow-up.
Munzarová M; Kovarík J; Hlávková J; Popelínský L; Lauerová L
Neoplasma; 1985; 32(1):45-50. PubMed ID: 3982560
[TBL] [Abstract][Full Text] [Related]
18. [2,4-dinitrochlorobenzene (DNCB) in the study of delayed hypersensitivity in some infectious diseases].
Cirelli A; D'Amato C; Lanzalone CM
Boll Soc Ital Biol Sper; 1974 Aug; 50(15):1157-62. PubMed ID: 4549182
[No Abstract] [Full Text] [Related]
19. Correlation between phytohemagglutinin skin test and delayed cutaneous hypersensitivity to dinitrochlorobenzene in cancer patients.
Sone S; Yata K; Tsubura E
Gan; 1976 Aug; 67(4):621-2. PubMed ID: 1024855
[No Abstract] [Full Text] [Related]
20. The prognostic significance of delayed hypersensitivity to dinitrochlorobenzene and mechlorethamine hydrochloride in cutaneous T cell lymphoma.
Vonderheid EC; Ekbote SK; Kerrigan K; Kalmanson JD; Van Scott EJ; Rook AH; Abrams JT
J Invest Dermatol; 1998 Jun; 110(6):946-50. PubMed ID: 9620303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]